Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    teriflunomide
Show Display Options
Download search resultsDownload the search results for:
teriflunomide (30 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Terminated Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
Conditions: Teriflunomide Elimination;   Healthy Volunteers
Interventions: Drug: teriflunomide;   Drug: Colestipol
2 Completed
Has Results
Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide);   Drug: Glatiramer Acetate (GA)
3 Completed
Has Results
Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for Teriflunomide);   Drug: Interferon-β
4 Completed Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Condition: Multiple Sclerosis
Intervention: Drug: TERIFLUNOMIDE HMR1726
5 Recruiting Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide
6 Completed
Has Results
Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide)
7 Completed Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (placebo for teriflunomide)
8 Completed
Has Results
Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo
9 Completed
Has Results
Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide);   Drug: Interferon-β [IFN-β];   Drug: Glatiramer Acetate [GA]
10 Not yet recruiting Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis
Condition: Relapsing Multiple Sclerosis
Interventions: Drug: Ofatumumab subcutaneous injection;   Drug: Placebo orally matching to teriflunomide;   Drug: Teriflunomide orally;   Drug: Placebo subcutanous injection matching to ofatumumab
11 Recruiting Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Condition: Relapsing Multiple Scelrosis
Interventions: Drug: Ofatumumab subcutaneous injection;   Drug: Placebo orally matching to teriflunomide;   Drug: Teriflunomide orally;   Drug: Placebo subcutaneous injection matching to ofatumumab
12 Terminated
Has Results
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta
Condition: Multiple Sclerosis Relapse
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide);   Drug: Interferon-beta (IFN-beta)
13 Completed
Has Results
An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Placebo;   Drug: Teriflunomide
14 Completed
Has Results
Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide
Condition: Multiple Sclerosis
Interventions: Drug: teriflunomide;   Drug: Interferon-β-1;   Biological: Influenza vaccine
15 Completed
Has Results
A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Interferon β-1a;   Drug: Teriflunomide
16 Enrolling by invitation Teriflunomide Observational Effectiveness Study
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: Teriflunomide
17 Completed A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide HMR1726;   Drug: cholestyramine
18 Completed Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: teriflunomide HMR1726;   Drug: cholestyramine;   Drug: charcoal
19 Completed Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months
Condition: Multiple Sclerosis
Intervention: Other: MRI
20 Recruiting Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide HMR1726;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years